Johnson & Johnson (LON:0R34)

London flag London · Delayed Price · Currency is GBP · Price in USD
215.21
-2.25 (-1.03%)
At close: Jan 21, 2026
45.22%
Market Cap390.98B
Revenue (ttm)69.85B
Net Income (ttm)19.88B
Shares Outn/a
EPS (ttm)8.18
PE Ratio19.67
Forward PE18.82
Dividend3.89 (1.81%)
Ex-Dividend DateNov 25, 2025
Volume5,060
Average Volume6,321
Open217.48
Previous Close217.46
Day's Range208.00 - 218.20
52-Week Range142.10 - 220.07
Betan/a
RSI61.15
Earnings DateJan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo... [Read more]

Industry Pharmaceutical Preparations
Founded 1886
Employees 138,100
Stock Exchange London Stock Exchange
Ticker Symbol 0R34
Full Company Profile

Financial Performance

In 2025, Johnson & Johnson's revenue was $94.19 billion, an increase of 6.05% compared to the previous year's $88.82 billion. Earnings were $26.80 billion, an increase of 90.56%.

Financial numbers in USD Financial Statements